Living with NonMelanoma Skin Cancer Symposium with University of Wisconsin, Madison
Living with NonMelanoma Skin Cancer Symposium with University of Wisconsin, Madison
Education is pivotal in empowering you to make informed decisions about your treatment options. It allows you to understand the nature of your disease, its progression, and available therapies. Armed with knowledge, you can actively participate in discussions with your healthcare team and collaborate on personalized treatment plans.
~Learn about the latest research and most advanced treatment options for skin cancer
~Discover strategies for maintaining quality of life
~Interact with renowned doctors and medical professionals
About The University of Wisconsin Melanoma and Skin Cancer Clinical Research
The University of Wisconsin’s melanoma/skin cancer group leads multiple industry-sponsored and federally-funded clinical trials evaluating novel drugs and therapeutic interventions for melanoma (cutaneous, mucosal, ocular), Merkel cell carcinoma, basal cell carcinoma and cutaneous squamous cell carcinoma.
Their faculty are international and site principal investigators on single- and multi-center Phase I through Phase III clinical trials. They also participate in translational research evaluating blood-based biomarkers to predict immunotherapy response/resistance for advanced stage melanoma.
Understanding Melanoma and Skin Cancer in People of Color with Dr Victoria Barbosa, President of the Skin of Color Society
June is National Cancer Survivor Month, and we’re celebrating the incredible stories of melanoma survivors!
Our special digital magazine is filled with inspiring journeys, resilience, and hope. From battles fought to triumphs celebrated, these stories are a testament to the strength and courage of our community.
Read their stories and learn about ways to become involved with our foundation. Together, we can continue to support and uplift each other.
#CancerSurvivorMonth #melanomasurvivor
Read/Download the Magazine:
https://issuu.com/aimatmelanoma/docs/national_cancer_survivor_month
Movement and Exercise During Cancer Treatment
Movement and Exercise During Cancer Treatment
Date & Time Jun 12, 2024 06:00 PM
Description In this enlightening webinar, discover the advantages of incorporating exercise into cancer treatment regimens. Our special guest, Kathryn H Schmitz, PhD, MPH, will share her expertise on the benefits of exercise for cancer patients and survivors.
Dr. Schmitz is a renowned Hematology/Oncology specialist and Visiting Professor of Medicine at UPMC. With her extensive background in Catchment Area Research and as the Leader of the Moving Through Cancer Program, she has dedicated her career to studying the effects of exercise on cancer patients.
During this webinar, Dr. Schmitz will discuss how regular physical activity can improve cancer treatment outcomes and enhance overall quality of life. She will also address common myths surrounding exercise during cancer treatment and provide practical tips for incorporating exercise into daily routines.
We chatted with renowned dermatologist Dr. Victoria Barbosa, as she shared her expert insights on skin health and sun protection for skin of color, hosted by our own Melissa Wilson, PA-C, MPAS, Lead Physician Assistant at UPMC Hillman Cancer Center and AIM's Ask a Medical Expert.
#SkinHealth #SunProtection #DermatologyLive #ExpertInsights #SummerReady #UPMCCancerCenter #skinofcolorsociety #skinofcolor #skinofcolorderm #skinofcolorexperts
Join us for a special #DontFryDay Instagram Live!
Spend 15 minutes with renowned dermatologist Dr. Victoria Barbosa, as she shares expert insights on skin health and sun protection for skin of color, hosted by our own Melissa Wilson, PA-C, MPAS, Lead Physician Assistant at UPMC Hillman Cancer Center and AIM's Ask a Medical Expert.
📅 Date: Friday, May 24
⏰ Time: 12:00 PM EST
Get your questions ready and learn how to keep your skin safe this summer! ☀️✨
#SkinHealth #SunProtection #DermatologyLive #ExpertInsights #SummerReady #UPMCCancerCenter #skinofcolorsociety #skinofcolor #skinofcolorderm #skinofcolorexperts
Did you know that Ultraviolet (UV) radiation from the sun is the primary cause of skin cancer, while heat itself is not directly responsible? 🌞 UV radiation, emitted naturally by the sun and artificially by sunbeds, is invisible and can't be felt. This makes it dangerous even on cloudy days!
Key Points to Remember:
UVA Rays: Penetrate deep into the skin, causing damage to elastic fibers and DNA. They account for 80% of visible skin aging.
UVB Rays: Affect the top layer of the skin, causing sunburn and triggering inflammatory responses.
Heat Stress: Exposure to heat stress, in addition to UV, could increase the accumulation of mutations in keratinocytes, possibly leading to the transformation of normal cells into pre-cancerous cells.
Understanding the difference between UV and heat is crucial for effective sun protection. Remember, it's the UV rays, not the heat, that pose the greatest risk to your skin.
🔗 Learn more and protect yourself this Memorial Day weekend at https://www.aimatmelanoma.org/melanoma-101/prevention/what-is-ultraviolet-uv-radiation/ 🔗
Stay safe and enjoy the sunshine responsibly! 🌞
#SunSafety #SkinCancerAwareness #ProtectYourSkin
Join us LIVE on Instagram this Friday featuring Melissa Wilson, PA-C, MPAS from AIM at Melanoma, and esteemed Board-Certified Dermatologist, Dr. Victoria Barbosa, MD 🍽️☀️✨ As the current President of the Skin of Color Society and a dedicated Health Equity Advocate, our guest brings unparalleled expertise, especially in the care and treatment of skin of color.
In a candid conversation, we’ll explore:
🔍 Strategies to lower melanoma risk for individuals of color.
🤝 How to find a dermatologist who understands your skin.
☀️ The #1 sun safety tip for people of color.
🧴 Sunscreens recommendations tailored for skin of color.
Whether you’re seeking to enrich your knowledge on sun safety, searching for skin care tips, or have specific concerns about melanoma, this chat promises to shed light on these vital topics.
Bring your questions. You don’t want to miss out on this opportunity to learn from the best in dermatology. See you there!
#LunchWithADerm #SkinHealth #SunSafety #Dermatology #SkinOfColor
The Angeles Clinic and Research Institute Symposium on Melanoma
The Angeles Clinic and Research Institute Symposium on Melanoma
The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments, and expertly guiding and training the next generation of clinicians.
Date: Saturday – May 11, 2024
Time: 12:00 PM (EST) | 11:00 AM (CST) | 10:00 AM (MST) | 9:00 AM (PST)
(double-check your local time with this time zone converter)
Format: Presented both virtually and in-person; Registration is required for both formats; please register below
Symposium Location: The Angeles Clinic and Research Institute, 11800 Wilshire Blvd, Los Angeles, CA 90025, 310-231-2120
This symposium is an opportunity for patients and caregivers to learn about melanoma from medical professionals and fellow patients, caregivers, and survivors. This event is FREE and open to all and will be presented in-person and virtually.
Presenters & Topics
9:00 AM PST
Welcome and Introductions @ The Angeles Clinic
Omid Hamid, MD
Chief, Translational Research & Immuno-Oncology
9:30 AM PST
Intelligent Immunotherapy Innovations in Initial Therapy
Justin T. Moyers, MD
The Angeles Clinic and Research Institute
Phase I & Experimental Therapeutics Program
10:00 AM PST
Mucosal, Acral, Uveal Futures – Time to Invest!
Inderjit Mehmi, MD
Medical Oncology
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate
10:30 AM PST
NeoAdjuvant & Adjuvant Therapy: Questions Getting Answered
Sapna Patel, MD
Chair SWOG Melanoma Committee, University of Colorado
Dr William Robinson Endowed Chair, Professor in Cancer Research
11:00 AM PST
Clinical Trial Options – New Data, Future Therapies
Ryan J. Sullivan, MD
Assistant Professor, Medicine, Harvard Medical School
11:20 AM PST
Cellular Therapy: TIL Tomorrow and Further
Mark B. Faries, MD
Co-Director, Melanoma Research Program
The Angeles Clinic & Research Institute, A Cedars-Si
Manage "Living With Skin Cancer Symposium with Oregon Health & Science University (OHSU)"
Manage "Living With Skin Cancer Symposium with Oregon Health & Science University (OHSU)"
Living With Skin Cancer Symposium with Oregon Health & Science University (OHSU)
About OHSU
OHSU is Oregon’s only public academic health center. They are a system of hospitals and clinics across Oregon and southwest Washington. They are an institution of higher learning, with schools of medicine, nursing, pharmacy, dentistry and public health – and with a network of campuses and partners throughout Oregon. They are a national research hub, with thousands of scientists developing lifesaving therapies and deeper understanding. They are a statewide economic engine and Portland’s largest employer. And as a public organization, they provide services for the most vulnerable Oregonians, and outreach to improve health in communities across the state.
Roswell Park Comprehensive Cancer Center | April 20, 2024
Roswell Park Comprehensive Cancer Center | April 20, 2024
This virtual and in-person symposium is presented by AIM at Melanoma and Roswell Park Comprehensive Cancer Center.
Founded in 1898 and operating from a 29-acre campus on the Buffalo Niagara Medical Campus (BNMC) near downtown Buffalo, New York, Roswell Park today remains the only comprehensive cancer center designated by the National Cancer Institute (NCI) in Upstate New York, and one of only four NCI-designated comprehensive cancer centers in all of New York. In the past year, Roswell Park teams cared for more than 46,000 patients. Roswell Park helps set international standards in cancer care through its role as a founding member of the National Comprehensive Cancer Network, and consistently earns patient-satisfaction scores that are among the highest in the country.
Date: Saturday, April 20, 2024
Time: 8:45 ET| 7:45 CT| 6:45 MT| 5:45 PT
Format: Presented both virtually and in-person; Registration is required for both formats; please register below
Symposium Location: Roswell Park Comprehensive Cancer Center, Buffalo Niagara Medical Campus, Research Studies Center, Elm Street. The symposium will be held in the Gaylord Cary Conference Room on the 1st floor in room 122.
Parking: Located across the street from the Research Studies Center, the entrance to the parking deck is located on Carlton Street.
roswell-campus-map-dec-2023_rsc-highlight
Presenters & Topics
8:15 AM ET
Registration For In-Person Attendees
8:45 AM ET
Welcome
9:00 AM ET
The Melanoma Primer for Patients
Ben Switzer, DO, MHSA, MS
Assistant Professor of Oncology, Department of Medicine
9:20 AM ET
Mole or Monster: Recognizing Melanoma
Gyorgy Paragh, MD, PhD
Associate Professor of Oncology
Chair, Department of Dermatology
9:40 AM ET
Behind the Scenes: The Modern Role of Pathology in Melanoma Care
Aleodor Andea, MD
Professor of Oncology
Chief, Dermatopathology, Department of Pathology
10:00 AM ET
Break
10:15 AM ET
Strategies for
Living With Melanoma Symposium with UPMC Hillman Cancer Center
Living With Melanoma Symposium with UPMC Hillman Cancer Center
This virtual and in-person symposium is presented by AIM at Melanoma and UPMC Hillman Cancer Center held at UPMC Hillman Cancer Center. UPMC Hillman Cancer Center is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center. They offer cancer care, research, and education for cancer researchers.
8:30am
Welcome
John M. Kirkwood, MD
Distinguished Service Professor of Medicine
Usher Professor of Medicine, Dermatology and Translational Science
Co-Leader, Melanoma and Skin Cancer Program
UPMC Hillman Cancer Center
Each presentation includes a 5-minute Q & A Session
8:40am
Management of Side Effects for BRAF/MEK Inhibitors
Melissa Wilson, PA-C, MPAS
Physician Assistant, Senior
UPMC Hillman Cancer Center
9:05am
Preventative Skin Care
Darcy Ploucha, PA-C, MPAS
Physician Assistant, Senior
UPMC Hillman Cancer Center
9:30am
Tissue Banking: Samples are Only Part of the Issue. What About the Data?
Mary Horak, BS, CCRP
Clinical Research Services
UPMC Hillman Cancer Center
9:55am
Can We Predict Who Will Respond to Immunotherapy?
Yana Najjar, MD
Assistant Professor of Medicine
UPMC Hillman Cancer Center
10:20am Break (10 minutes)
10:30am
Role of Diet and Gut Microbiota in Determining Response and irAEs
Diwakar Davar, MD
Assistant Professor of Medicine
UPMC Hillman Cancer Center
10:55am
Pediatric Melanoma – The Time is Now for a Standard Treatment Approach
Brittani Seynnaeve, MD, MS
Associate Fellowship Program Director
Pediatric Melanoma Program Director
Division of Pediatric Hematology/Oncology, Department of Pediatrics
UPMC Children’s Hospital of Pittsburgh
11:20am
Closing Remarks
Ann Garst Taylor
Director of Community Engagement
AIM at Melanoma
The FDA Approval of TIL Therapy and What it Means for Advanced Melanoma
The FDA Approval of TIL Therapy and What it Means for Advanced Melanoma
An exciting new development in melanoma treatment is the recent FDA-approval of Lifileucel (AMTAVGI) therapy, which harnesses the power of the body's own immune cells to recognize and attack melanoma cells.
We're thrilled to invite you to attend an exclusive webinar that will delve into this newly-approved treatment and its implications for melanoma care. The webinar will feature Dr. Allison Betof Warner, a leading expert in TIL therapy, in conversation with Samantha Guild, JD, President of AIM at Melanoma.
Moores Cancer Center at UC San Diego Health
Moores Cancer Center at UC San Diego Health
Established in 1978, Moores Cancer Center is one of just 53 National Cancer Institute-Designated Comprehensive Cancer Centers in the United States, and the only one in the San Diego region. Such centers are prominent among the leading institutions in the nation dedicated to scientific innovation and clinical excellence. This designation — reserved for centers with the highest achievements in cancer research, clinical care, education and community contributions — makes an enormous difference to their patients. Studies show that outcomes are better at NCI-designated centers. Their cancer services were ranked #1 in San Diego, with 10 specialties ranking nationally by U.S. News & World Report in its 2022-2023 “Best Hospitals” survey.
Date: Saturday – February 17, 2024
Time: 12:00 PM (ET)| 11:00 AM (CT) | 10:00 AM (MT) | 9:00 AM (PT)
Format: Presented both virtually and in-person; Registration required for both formats, please register below
Symposium Location: Moores Cancer Center, University of California, San Diego, Goldberg Auditorium 2nd Floor, 3855 Health Sciences Dr, San Diego, CA
Parking: Athena Parking Structure
• Drive southeast on Genesee Ave
• Turn right onto Regents Road
• Turn right onto Health Sciences Dr
• Parking structure will be on the right and across the street from the Moores Cancer Center
• Turn right to enter the structure.
Presenters & Topics
8:30 AM PT
Registration For In-Person Attendees
9:00 AM PT
Welcome & Opening Remarks
Gregory A Daniels, MD, PhD
Medical Oncologist
Professor of Medicine
UC San Diego Health Moores Cancer Center
9:10 AM PT
The Making of Melanoma
Kenneth Linden, PhD, MD
Professor
Department of Dermatology
Chow Family Comprehensive Cancer Center
Co-Director, University of California Irvine Melanoma Center
Co-Director, Skin Disease Oriented Team; UC Irvine
Chair, Institutional Review Board; UC Irvine
9:30 AM PT
Through The Lens Of An Ocular Oncologist
Treating Advanced Nonmelanoma Skin Cancers
Treating Advanced Nonmelanoma Skin Cancers
Topic
Treating Advanced Nonmelanoma Skin Cancers
Description
Exciting news! Join us for a special interview with Melissa Wilson, PA-C, MPAS, and Krista Rubin, MS, FNP-BC, a Family Nurse Practitioner (FNP-BC) at Mass General Cancer Center in Boston, MA, AIM at Skin Cancer's "Ask a Nurse," and host of a new skin cancer webinar series, "Skin Cancer & YOU.
Melissa and Krista will discuss the latest advancements in nonmelanoma skin cancer treatment. Discover the groundbreaking breakthroughs that are shaping the future of skin cancer care.
Krista Rubin MS, FNP-BC
Nurse Practitioner, Center for Melanoma, Massachusetts General Hospital, AIM at Skin Cancer's "Ask a Skin Cancer Nurse"
Krista Rubin is a Nurse Practitioner in the Melanoma Disease Center at Massachusetts General Hospital in Boston. She has been involved in the care of patients with melanoma and nonmelanoma skin cancers for the past 20+ years. She has extensive expertise in the diagnosis, management and treatment of patients with both early and late-stage skin cancers. She lectures internationally and has authored numerous articles on the topic of skin cancer.
AIM at Skin Cancer Nonmelanoma Skin Cancer Patient Symposium with Dana-Farber Cancer Institute
AIM at Skin Cancer Nonmelanoma Skin Cancer Patient Symposium with Dana-Farber Cancer Institute
Founded in 1947, Dana-Farber Cancer Institute is committed to providing adults and children with cancer the best treatments available today, while leading the research to advance the understanding, diagnosis, treatment, cure and prevention of cancer and related diseases. Located in Boston, Massachusetts, Dana-Farber is a Comprehensive Cancer Center as designated by the National Cancer Institute and an affiliate of the Harvard Medical School.
This symposium is an opportunity for patients and caregivers to learn about nonmelanoma skin cancers from the medical experts from Dana-Farber Cancer Institute. This event is FREE and open to all and will be presented virtually.
Agenda
Co-Chairs:
Ann W. Silk, MD
Justine V. Cohen, DO
Introduction to the Types of Skin Cancer – Ann W. Silk, MD
Cutaneous Squamous Cell Carcinoma (cSCC) and Basal Cell Carcinoma (BCC)
~Introduction to Mohs Surgery– Abigail H Waldman, MD, FAAD
~Treatment Options for Metastatic cSCC – Justine Cohen, DO
Merkel Cell Carcinoma (MCC)
~Diagnosis of MCC and Next Steps– Manisha Thakuria, MD
~Radiation Therapy for the Treatment of MCC– Danielle Margalit, MD
~Treatments Options for Metastatic MCC – Karam Khaddour, MD
AIM at Skin Cancer Resources – Ann Garst Taylor
Panel Discussion with Q&A – moderated by Justine V. Cohen, DO
Panelists:
Justine V. Cohen, DO
Nancy Crehan, LICSW
Lilly Flanagan, Physician Assistant
Alexis Giacco, MSW, LCSW
Karam Khaddour, MD
Arianna Maida, Physician Assistant
Danielle Margalit, MD
Ann W. Silk, MD
Ann Garst Taylor
Manisha Thakuria, MD
Cassie Yerkes, RN
Abigail H. Waldman, MD, FAAD
The Future of Melanoma Treatment in 2024
The Future of Melanoma Treatment in 2024
Hosted by Anthony J. Olszanski, MD, RPh, and Jeffrey M. Farma, MD, FACS , Co-Directors of Fox Chase Cancer Center’s Melanoma and Skin Cancer Program.
Discover the latest advancements, breakthrough therapies, and cutting-edge research revolutionizing melanoma treatment.
Topics to be discussed include:
~What the anticipated approval of TILs therapy will mean for patients with melanoma
~New surgical and systemic options for the treatment of patients with melanoma
~Clinical trials to look for in 2024
~Two case studies
Don't miss this opportunity to stay ahead of the curve in melanoma research and care.
We've compiled all 12 Beyond the Clinic: Living Well With Melanoma episodes from 2023 into a digital magazine. By condensing the content into one easily accessible format, the magazine provides an organized summary of each show, allowing you to browse and listen at your leisure.
Join us in celebrating the amazing guests and moments that made our show unforgettable.
Click below to access.
https://issuu.com/aimatmelanoma/docs/december_2023_newsletter
T.W. Lewis Melanoma Center of Excellence at Banner MD Anderson Cancer Center
T.W. Lewis Melanoma Center of Excellence at Banner MD Anderson Cancer Center
The team at the T.W. Lewis Melanoma Center of Excellence at Banner MD Anderson Cancer Center combines innovative research, advanced technologies, and an integrated approach to provide individualized treatment for each of our patients.
Through our Melanoma and Skin Cancer Program, you’ll have access to the leading care from some of the nation’s skin health experts including surgical oncologists, medical oncologists, radiation oncologists, radiologists, nurses, and therapists.
Our melanoma program offers all the services needed to treat the whole person – not just the disease –in one location. Whether you’ve been diagnosed with melanoma or need additional screening or diagnostics, our collaborative multidisciplinary team will provide you with truly customized care and serve as a helpful resource every step of the way.
Date: Saturday – December 2, 2023
Time: 11 AM (ET) 10:00 AM (CT) 9:00 AM (MT) 8:00 AM (PT)
(double-check your local time with this time zone converter)
Location: This is an in-person and virtual presentation
Getting to the Symposium:
This symposium will be held at Banner MD Anderson Cancer Center in Gilbert (US 60 and Higley Road). 2946 E. Banner Gateway Drive, Gilbert, AZ 85234
Parking is available on the north side of the Cancer Center, parallel to the US 60 freeway. Once you walk through the lobby front doors, you will be greeted by volunteers who will get you checked in and will show you to the Coyote Mountain Conference room on the 2nd floor, where the symposium will be held.
Presenters & Topics
8:30 AM (MT)
Registration and Breakfast
9:00 AM (MT)
Welcome and Introductions
Mark Gimbel, MD
Medical Director, T.W. Lewis Melanoma Center of Excellence
Surgical Oncology
Banner MD Anderson Cancer Center
9:10 AM (MT)
Genetics and Melanoma
Jordan Abbott, MD
Onco-Dermatologist
Banner MD Anderson Cancer Center
9:30 AM (MT)
It’s Melanoma, Now What?
Mark Gimbel,
Atrium Health Levine Cancer Symposium
Atrium Health Levine Cancer Symposium
As one of the leading and most innovative cancer programs in the country, Atrium Health Levine Cancer operates within a unique model of care that provides diverse communities access to world-class care across the Carolinas. This academic hybrid model combines two important bodies of work – academics and oncology research – with compassionate, community-based cancer care. In the Greater Charlotte region, Levine Cancer has been recognized by US News and World Report as one of the top 50 cancer centers in the country.
This symposium is an opportunity for patients and caregivers to learn about melanoma from medical professionals and fellow patients, caregivers, and survivors. This event is FREE and open to all and will be presented virtually.
Date: Saturday – November 11, 2023
Time: 10:00 AM (ET) | 9:00 AM (CT) | 8:00 AM (MT) | 7:00 AM (PT)
(double-check your local time with this time zone converter)
Presenters & Topics
10:00 – 10:05 AM (ET)
Welcome
Asim Amin, MD, PhD
Medical Oncologist,
Co-Director of Immunotherapy,
Atrium Health Levine Cancer
10:05 – 10:25 AM (ET)
New Diagnosis of Melanoma – The Patient Perspective
Asim Amin, MD
Medical Oncologist,
Co-Director of Immunotherapy,
Atrium Health Levine Cancer
10:25 – 10:45 AM (ET)
Toxicities Associated with Melanoma Therapies and Treatment
Jennifer Atlas, MD
Medical Oncologist,
Atrium Health Levine Cancer
10:45 – 11:05 AM (ET)
Surgical Management of Melanoma in 2023
Malcolm Squires, MD
Surgical Oncologist,
Assistant Professor of Surgery, Division of Surgical Oncology
Atrium Health Levine Cancer
11:05 – 11:25 AM (ET)
Financial Toxicity: The Cost of Cancer Treatment in Patients with Melanoma
Jessica Davis, PharmD, BCOP, CPP
Clinical Pharmacist Coordinator, Adult Hematology/Oncology,
Atrium Health Levine Cancer
11:25 – 11:30 AM (ET)
Patient Resources
Ann Garst Taylor
Director of Community Engagement,
AIM at Melanoma
11:30 AM – 12:00 PM (ET)
Q&A